Treatment of patients with primary open-angle glaucoma with a fixed combination of brimonidine 0.2%/timolol 0.5%: multicenter, open-label, observational study in Germany.


OBJECTIVE At the introduction of the fixed-combination of brimonidine/timolol in Germany in 2006, a non-interventional, multicenter, observational, open-label study was initiated to evaluate efficacy, tolerability, and safety of this preparation in a broad patient population. METHODS The study population comprised patients with bilateral primary open… (More)
DOI: 10.1185/03007990902805916


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.